AWM
QNTM

Avior Wealth Management’s Quantum Biopharma Class B Subordinate Voting Shares QNTM Stock Holding History

Avior Wealth Management’s Portfolio QNTM Stock Details QNTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3
Closed -$11 – 2432
2024
Q4 		$11 Hold
3
– – ﹤0.01% 2448
2024
Q3 		$12 Buy
+3
New +$19 ﹤0.01% 2300

Other funds holding QNTM

AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
JWCA
J.W. Cole Advisors Tampa, Florida $5.83B AUM 32.38% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TIM
Thompson Investment Management Madison, Wisconsin $872M AUM 35.59% 1-Year Est. Return
CTC
Cetera Trust Company St. Paul, Minnesota $177M AUM 28.75% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

Avior Wealth Management's QNTM Position: Q1 2025 in Review

Avior Wealth Management sold out of Quantum Biopharma Class B Subordinate Voting Shares (QNTM) in Q1 2025, closing a stake of 3 shares — an estimated $11 sold.

Avior Wealth Management first reported a position in QNTM in Q3 2024 and held it in 2 quarters. The position peaked at $12 in Q3 2024. 14 funds tracked by Wall St. Rank hold QNTM as of Q1 2025.

  • Avior Wealth Management reported no remaining Quantum Biopharma Class B Subordinate Voting Shares position as of Q1 2025 after selling out during the quarter.
  • Avior Wealth Management sold 3 Quantum Biopharma Class B Subordinate Voting Shares shares in Q1 2025, an estimated $11.
  • Avior Wealth Management first reported a position in Quantum Biopharma Class B Subordinate Voting Shares in Q3 2024 and held it in 2 quarters.
  • Avior Wealth Management's Quantum Biopharma Class B Subordinate Voting Shares position peaked at $12 in Q3 2024.
  • 14 funds tracked by Wall St. Rank held Quantum Biopharma Class B Subordinate Voting Shares as of Q1 2025.

Based on Avior Wealth Management's 13F filing for Q1 2025, filed 21 Apr 2025.